Journals / art / 2016 / Cilt: 31 - Sayı: 4

Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome

Journal
art
Pages
388–389
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

MEARA, A., CHAN, R., HUSA, M. (2016). Management Decisions for Rheumatoid Arthritis After Tumor Necrosis Factor Alpha Antagonist-Induced Lupus-Like Syndrome. art, Cilt: 31 - Sayı: 4, 388–389. https://ajindex.com/articles/178191

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Williams EL, Gadola S, Edwards CJ. Anti-TNF- induced lupus. Rheumatology (Oxford) 2009;48:716- 20. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 2008;37:381-7.
  2. Moulis G, Sommet A, Lapeyre-Mestre M, Montastruc JL. Is the risk of tumour necrosis factor inhibitor- induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/ non-case study in a nationwide pharmacovigilance database. Rheumatology (Oxford) 2014;53:1864-71.
  3. Almoallim H, Al-Ghamdi Y, Almaghrabi H, Alyasi O. Anti-Tumor Necrosis Factor-a Induced Systemic Lupus Erythematosus. Open Rheumatol J 2012;6:315-9.
  4. Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 2008;22:847-61.
  5. Ramos-Casals M, Brito-Zerón P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 2008;22:847-61.
  6. Williams VL, Cohen PR. TNF alpha antagonist- induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 2011;50:619-25.
  7. Santiago T, Santiago MG, Rovisco J, Duarte C, Malcata A, da Silva JA. A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-a agent? Clin Rheumatol 2013;32:1819-22.